• Charles R Rogers, Michael J Rovito, Musse Hussein, Ogechi Jessica Obidike, Rebekah Pratt, Mark Alexander, Jerica M Berge, Marc Dall'Era, Jeffrey W Nix, and Christopher Warlick.
• Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah. Electronic address: charles.rogers@utah.edu.
• Am J Prev Med. 2018 Nov 1; 55 (5 Suppl 1): S103S111S103-S111.

IntroductionBlack men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted.MethodsA community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men's attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017.ResultsIdentified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent.ConclusionsDisparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research.Supplement InformationThis article is part of a supplement entitled African American Men's Health: Research, Practice, and Policy Implications, which is sponsored by the National Institutes of Health.Copyright © 2018. Published by Elsevier Inc.

33 keywords...

hide…